Sergey Kamishov

Eng koʻp iqtibos qilingan asarlar

1. Colon cancer: Pharmacogenetic approach to personalized conservative treatment20170 iqtibos
2. The efficacy of PARP inhibitors in the treatment of patients with synchronous breast cancer.20240 iqtibos
3. Possibilities of long-term atezolizumab immunotherapy in patients with metastatic urothelial cancer.20240 iqtibos
4. Immunohistochemical markers in the prognostic model for survival of patients with diffuse large B-cell lymphoma.20240 iqtibos
5. The outcomes of atezolizumab therapy in combination with carboplatin and etoposide for small-cell lung cancer.20240 iqtibos
6. Effectiveness and safety of combined therapy with pemetrexed and bevacizumab in recurrent and metastatic cervical cancer.20250 iqtibos
7. Results of combined therapy with pemetrexed and carboplatin in progressive ovarian cancer.20250 iqtibos
8. Next-generation sequencing–based mutation profiling in solid tumors: A study from a north Indian tertiary care center.20260 iqtibos
9. Immunotherapy for advanced gastric cancer: Experience from Uzbekistan.20260 iqtibos

Hammualliflar

1. Kamila Izrailbekova6 ta umumiy asar2024–2026
2. Mirzagaleb Tillyashaykhov5 ta umumiy asar2024–2025
3. Odiljon Kobilov5 ta umumiy asar2024–2025
4. Shakhnoza Niyozova3 ta umumiy asar2025–2026
5. Oleg Balenkov3 ta umumiy asar2024–2025
6. Shakhnoza Khamoydinovna Niyozova3 ta umumiy asar2024
7. Meri Lipartiya2 ta umumiy asar2024
8. Dilshod Rafiev2 ta umumiy asar2024
9. Dinesh Pendharkar1 ta umumiy asar2026
10. Askar Adilkhodjaev1 ta umumiy asar2026

Barcha hammualliflar →